Please login to the form below

Not currently logged in
Email:
Password:

celecoxib

This page shows the latest celecoxib news and features for those working in and with pharma, biotech and healthcare.

Products over pipeline in Pfizer's acquisition targets, hints CEO

Products over pipeline in Pfizer's acquisition targets, hints CEO

Most damaging to Pfizer's top-line this year was the loss of patent protection for big-selling painkiller Celebrex  (celecoxib) last December in the US, with competition already being felt

Latest news

More from news
Approximately 3 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Immunocore names CEO Immunocore names CEO

    During this time he helped bring several drugs to markets including Celebrex (celecoxib) and Relpax (eletriptan) and to establish the company in India and China.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics